Arturo Loaiza-Bonilla, MD, Will Be a Speaker at Decentralized Clinical Trials Conference
2023.04.19

The emergence of decentralized clinical trials (DCTs) in recent years has been one of the most significant developments in the world of pharmaceutical research. The value and potential of DCTs to transform many aspects of clinical research will be discussed at Decentralized Clinical Trials, a conference presented by Informa in collaboration with the Tufts Center for the Study of Drug Development on April 18-20 at the Marriott Cambridge, Boston, in Cambridge, Massachusetts.
This event will bring together leading figures in cancer clinical research, including Massive Bio Co-founder and Chief Medical Officer Arturo Loaiza-Bonilla, MD, who will deliver a presentation and participate in a panel discussion. In “Experience of Decentralized Trials,” on April 18, Loaiza-Bonilla will talk about how DCTs can help increase diversity in clinical research. On April 19, Loaiza-Bonilla will be a panelist in a session titled “How DCT Technology has Changed the Relationship/Partnership Between Sponsor, CRO and Investigator.”
Decentralized Clinical Trials is an in-person event. On-demand access to all presentation recordings will be available starting April 26.
Recent In Massive Bio

Arturo Loaiza-Bonilla, MD, Will Be a Speaker at Decentralized Clinical Trials Conference
2023.04.19

The April Issue of Massive Bio Magazine is Now Available
2023.04.17

News Can ChatGPT Help Increase Enrollment in Cancer Clinical Trials?
2023.04.12

Massive Bio Chief Medical Officer Will Speak at Oncology Education Retreat
2023.04.11

Arturo Loaiza-Bonilla, MD, Delivers Keynote Speech at NCODA International Spring Forum
2023.04.04